• DME Advisors, DME Capital Management cut their Solvay voting rights stake below the 5% disclosure threshold.
• Holding fell to 4.96% as of Aug. 31, from above 5% previously.
• Disclosure dated Sept. 4 cited a transfer of voting-right securities; no financial instruments were reported.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Solvay SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609081145OMX_____EUPR__NL_GNW1001261644_nl) on September 08, 2026, and is solely responsible for the information contained therein.